Nuvation Bio (NUVB) Return on Equity (2023 - 2025)
Historic Return on Equity for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to 0.62%.
- Nuvation Bio's Return on Equity rose 7800.0% to 0.62% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.62%, marking a year-over-year increase of 7800.0%. This contributed to the annual value of 1.06% for FY2024, which is N/A changed from last year.
- According to the latest figures from Q3 2025, Nuvation Bio's Return on Equity is 0.62%, which was up 7800.0% from 0.51% recorded in Q2 2025.
- Nuvation Bio's Return on Equity's 5-year high stood at 0.11% during Q1 2024, with a 5-year trough of 1.4% in Q3 2024.
- Over the past 3 years, Nuvation Bio's median Return on Equity value was 0.9% (recorded in 2024), while the average stood at 0.82%.
- Examining YoY changes over the last 5 years, Nuvation Bio's Return on Equity showed a top increase of 7800bps in 2025 and a maximum decrease of -12600bps in 2025.
- Quarter analysis of 3 years shows Nuvation Bio's Return on Equity stood at 0.12% in 2023, then crashed by -843bps to 1.18% in 2024, then skyrocketed by 47bps to 0.62% in 2025.
- Its last three reported values are 0.62% in Q3 2025, 0.51% for Q2 2025, and 1.37% during Q1 2025.